Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor

Cannabidiol (CBD), the major non-psychotomimetic compound present in the Cannabis sativa plant, exhibits therapeutic potential for various human diseases, including chronic neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, ischemic stroke, epilepsy and other convulsive syndromes, neur...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Muñoz, María, Onetti, Yara, Cortés-Montero, Elsa, Garzón, Javier, Sánchez-Blázquez, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142691/
https://www.ncbi.nlm.nih.gov/pubmed/30223868
http://dx.doi.org/10.1186/s13041-018-0395-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142691/
https://www.ncbi.nlm.nih.gov/pubmed/30223868
http://dx.doi.org/10.1186/s13041-018-0395-2

Ejemplares similares